Fundraising Fox
🦊/Companies
Sign in

Santa Ana Bio

Alameda, US · Founded 2020 · Delaware corporation · 34 employees on LinkedIn · 5 known investors

Find your way into Santa Ana Bio

1,363 people in our graph share verified history with the Santa Ana Bio team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Ansuman Satpathy · together at Stanford University (overlapped)
×6knows the team · via Stanford University
knows the team · via University of Illinois Urbana-Champaign
knows the team · via Cartography Biosciences
×2knows the team · via Stanford University School of Medicine
knows the team · via Washington University School of Medicine in St. Louis

Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases. The company uses precision therapeutics designed to either suppress overactive immune responses or reactivate dormant ones.

BiotechMedical Devices

Founders & leadership

Santa Ana Bio was founded in 2020 by Peter Emtage, Alexander Rudensky, Richard Flavell, Graham Lord, and Ansuman Satpathy.

PEPeter Emtage
Peter EmtageinFounder & CEOVenture Partner at Versant Ventures
AR
Alexander RudenskyScientific Founder
RF
Richard FlavellScientific Founder
GLGraham Lord
Graham LordinScientific Founder
ASAnsuman Satpathy
Ansuman Satpathyin𝕏Scientific FounderAdvisory Venture Partner at Wing

Board

TWThomas Woiwode
Thomas WoiwodeinBoard directorManaging Director at Versant Ventures
JDJerel Davis
Jerel Davisin𝕏Board MemberManaging Director at Versant Ventures

Investors · 5

Access BiotechnologyNew York City
Andreessen HorowitzMenlo Park · $500K – $50M
GV (Google Ventures)Mountain View · $250K – $50M
Versant Venture CapitalreportedSan Francisco
Versant Venturesreported · 2 sourcesSan Francisco · $250K – $5M

Reported raises · per SEC filings

Form D private placements

$63.3M disclosed across 3 rounds · 2021–2024

▶$20MraisedJun 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mittie DoyleDirector
  • Peter EmtageExecutive Officer, Director
  • Jerel DavisDirector
  • Shinichiro FuseDirector
  • Brendan Bulik-SullivanDirector
  • Christine BorowskiDirector
  • Marcelo BigaloDirector
Offering amount
$125M
Amount sold
$20M
First sale
May 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35.3MraisedFeb 2023 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shinichiro FuseDirector
  • Thomas WoiwodeDirector
  • Brendan Bulik-SullivanDirector
  • Jerel DavisDirector
  • Peter EmtageExecutive Officer, Director
Offering amount
$70.3M
Amount sold
$35.3M
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas WoiwodeDirector
  • Peter EmtageExecutive Officer, Director
  • Jerel DavisExecutive Officer, Director
Offering amount
$42M
Amount sold
$8M
First sale
May 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Santa Ana Bio went on to found or lead other companies.

Ansuman SatpathyScientific FounderFounded Santa Ana +3Peter EmtageFounder & CEOFounded Santa AnaMarcelo BigalBoard MemberFounded Ventus Therapeutics

In the news

Santa Ana Bio emerges from stealth with $168mbioprocessintl.com · Jun 2024Santa Ana Bio Raises $168M in Fundingfinsmes.com · Jun 2024Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases - BioSpacebiospace.com · Jun 2024Santa Ana Bio Launches With $168 Million to Advance Precision Medicines for Inflammatory Diseases - BioSpacebiospace.com · Jun 2024

Frequently asked questions

What does Santa Ana Bio do?
Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases. The company uses precision therapeutics designed to either suppress overactive immune responses or reactivate dormant ones.
Who founded Santa Ana Bio?
Santa Ana Bio was founded by Peter Emtage, Alexander Rudensky, Richard Flavell, Graham Lord, Ansuman Satpathy in 2020.
Who are Santa Ana Bio's investors?
Santa Ana Bio's investors include Access Biotechnology, Andreessen Horowitz, GV (Google Ventures), Versant Venture Capital, Versant Ventures.
How much funding has Santa Ana Bio raised?
Santa Ana Bio has disclosed $63.3M raised across 3 rounds.
Where is Santa Ana Bio headquartered?
Santa Ana Bio is headquartered in Alameda, US.